Search

Europe’s small biotechs have leapt to take advantage of the European Medicines Agency’s (EMEA) office for SMEs, according to a review of its first year in operation.

The latest OECD research on Japan provides a warning to Europe that merely spending more does not make innovation spring forth.

Seven of London’s leading medical research institutions created an independent company to broker partnerships in the field of genetics and genomics.

The Czech Republic became a full member of the European Southern Observatory on 1 January, following a signing ceremony in Prague in December.

As Germany takes over the six-month rotating presidency of the European Union from Finland, there's little evidence of new thinking about innovation.

For research investors, 2006 was the year that the European train finally started to leave the station. The new year will tell whether it’s going anywhere worth visiting.

The US federal spending on R&D continues its skyward progression.